Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3127815rdf:typepubmed:Citationlld:pubmed
pubmed-article:3127815lifeskim:mentionsumls-concept:C0020155lld:lifeskim
pubmed-article:3127815lifeskim:mentionsumls-concept:C0039644lld:lifeskim
pubmed-article:3127815lifeskim:mentionsumls-concept:C0013072lld:lifeskim
pubmed-article:3127815lifeskim:mentionsumls-concept:C0150097lld:lifeskim
pubmed-article:3127815lifeskim:mentionsumls-concept:C1527358lld:lifeskim
pubmed-article:3127815lifeskim:mentionsumls-concept:C0243072lld:lifeskim
pubmed-article:3127815pubmed:issue6lld:pubmed
pubmed-article:3127815pubmed:dateCreated1988-5-6lld:pubmed
pubmed-article:3127815pubmed:abstractTextA double blind cross-over phototoxicity study using demethylchlortetracycline (DMCT) 0.3 g x 2, doxycycline 0.1 g x 2, lymecycline 0.6 g x 2 and placebo was performed on 8 healthy human volunteers. Drugs were given for 3 consecutive days, and on the third day the volunteers were tested with different modalities of artificial long-wave ultraviolet radiation (UVA) and assessed 24 h later for objective as well as subjective abnormal photoreactions. All 4 substances were tested in each individual at weekly intervals and serum concentrations of tetracycline were determined. It was found most convenient to irradiate relatively large skin areas using fluorescent tubes emitting mainly UVA but also a small proportion of UVB. Using this type of irradiation, weak erythemal reactions were obtained with all 3 derivatives. Taking only stronger reactions and stinging sensations into account, 0/8 reacted to lymecycline, 0/8 to DMCT and 4/8 to doxycycline. There was no significant difference in serum concentration among the 3 derivatives. It is concluded that doxycycline is the most potent photosensitizer at the dosage tested.lld:pubmed
pubmed-article:3127815pubmed:languageenglld:pubmed
pubmed-article:3127815pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3127815pubmed:citationSubsetIMlld:pubmed
pubmed-article:3127815pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3127815pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3127815pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3127815pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3127815pubmed:statusMEDLINElld:pubmed
pubmed-article:3127815pubmed:monthDeclld:pubmed
pubmed-article:3127815pubmed:issn0108-9684lld:pubmed
pubmed-article:3127815pubmed:authorpubmed-author:LjunggrenBBlld:pubmed
pubmed-article:3127815pubmed:authorpubmed-author:BjellerupMMlld:pubmed
pubmed-article:3127815pubmed:issnTypePrintlld:pubmed
pubmed-article:3127815pubmed:volume4lld:pubmed
pubmed-article:3127815pubmed:ownerNLMlld:pubmed
pubmed-article:3127815pubmed:authorsCompleteYlld:pubmed
pubmed-article:3127815pubmed:pagination281-7lld:pubmed
pubmed-article:3127815pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:3127815pubmed:meshHeadingpubmed-meshheading:3127815-...lld:pubmed
pubmed-article:3127815pubmed:meshHeadingpubmed-meshheading:3127815-...lld:pubmed
pubmed-article:3127815pubmed:meshHeadingpubmed-meshheading:3127815-...lld:pubmed
pubmed-article:3127815pubmed:meshHeadingpubmed-meshheading:3127815-...lld:pubmed
pubmed-article:3127815pubmed:meshHeadingpubmed-meshheading:3127815-...lld:pubmed
pubmed-article:3127815pubmed:meshHeadingpubmed-meshheading:3127815-...lld:pubmed
pubmed-article:3127815pubmed:meshHeadingpubmed-meshheading:3127815-...lld:pubmed
pubmed-article:3127815pubmed:meshHeadingpubmed-meshheading:3127815-...lld:pubmed
pubmed-article:3127815pubmed:meshHeadingpubmed-meshheading:3127815-...lld:pubmed
pubmed-article:3127815pubmed:meshHeadingpubmed-meshheading:3127815-...lld:pubmed
pubmed-article:3127815pubmed:year1987lld:pubmed
pubmed-article:3127815pubmed:articleTitleDouble blind cross-over studies on phototoxicity to three tetracycline derivatives in human volunteers.lld:pubmed
pubmed-article:3127815pubmed:affiliationDepartment of Dermatology, General Hospital, Lund University, Malmö, Sweden.lld:pubmed
pubmed-article:3127815pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3127815pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:3127815pubmed:publicationTypeControlled Clinical Triallld:pubmed